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The pathogenic properties of four primary human immunodeficiency virus type 2 (HIV-2) isolates
and two primary HIV-2 biological clones were studied in an in vivo human-to-mouse chimeric
model. The cell-associated viral load and the ability to reduce the severity of the induced graft-
versus-host disease symptoms, the CD4/CD8 ratio and the level of repopulation of the mouse
tissues by the graft, were determined. All HIV-2 strains, irrespective of their in vitro biological
phenotype, replicated to high titres and significantly reduced graft-versus-host disease symptoms
as well as the CD4/CD8 ratios. Reduction of graft repopulation caused by infection with the
respective HIV-2 strains showed that the in vitro replication rate, syncytium-inducing capacity and
ability to infect human macrophages did influence the in vivo pathogenic potential whereas
broadening of coreceptor usage did not.
Introduction
Human immunodeficiency virus types 1 and 2 (HIV-1 and
HIV-2) are the causative agents of AIDS (Barre-Sinoussi et al.,
1983 ; Clavel et al., 1986 ; Levy et al., 1986). The most
prominent feature of the pathogenesis of AIDS is the
quantitative and qualitative deterioration of the CD4+ T cell
subset. Although CD4+ T cells are already affected soon after
infection, it may take from 1 to more than 15 years before
immune failure leads to overt clinical symptoms (Gruters et al.,
1990, 1991). Both virological and host-delimited factors have
been shown to determine the length of the asymptomatic
period (Cheng-Mayer et al., 1988 ; Dean et al., 1996 ; Fenyo et
al., 1988 ; van Baalen et al., 1997). Epidemiological studies have
shown that, although progression to AIDS may in specific
cases be relatively fast, disease progression in HIV-2-infected
individuals is in general much slower than disease progression
in HIV-1-infected individuals (Marlink et al., 1994 ; Whittle et
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al., 1994 ; van der Ende et al., 1996). Virological factors which
underlie this difference between HIV-1- and HIV-2-induced
disease progression are presently not known. Studies in in vitro
and in vivo systems, specifying viral characteristics which
determine the pathogenicity of HIV strains, may aid in the
understanding of HIV-induced pathogenesis.
The characteristics used to classify HIV strains in vitro
include replication rate, ability to induce the formation of
multinucleated cells [syncytium-inducing (SI) capacity], co-
receptor requirement and ability to infect different target cells
(T cell lines versus macrophages) (Asjo$ et al., 1986 ; Berger et
al., 1998 ; Cheng-Mayer et al., 1988 ; Schuitemaker et al.,
1992b ; Tersmette et al., 1989). For HIV-1 it has been shown
that these in vitro characteristics exhibit a high degree of
correlation. For example, SI strains in general have a high
replication rate, infect target cells via a and b chemokine
receptors, may infect immortalized T cell lines and only infect
macrophages inefficiently. NSI strains, on the other hand, have
a low replication rate, require expression of b chemokine
receptors, do not infect T cell lines and replicate efficiently in
macrophages (Berger et al., 1998 ; Schuitemaker et al., 1991). It
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should, however, be noted that individual virus strains may
also display intermediate biological phenotypes (Groenink et
al., 1991 ; Sabri et al., 1996 ; Schuitemaker et al., 1992a). Several
differences in in vitro characteristics of HIV-1 and HIV-2 have
become apparent. The replication rate, as defined by the time
required to detect virus after initiation of standard virus culture
from donor peripheral blood mononuclear cells (PBMC), is
generally lower for HIV-2 than for HIV-1 (Albert et al.,
1990 ; van der Ende et al., 1996). Furthermore, we and others
have recently shown that clear differences exist in coreceptor
requirements (Guillon et al., 1998 ; McKnight et al., 1998). The
linkage between HIV-1 SI phenotype and CXCR-4 coreceptor
usage was not observed for HIV-2. Furthermore, HIV-2 strains
in general have a broader coreceptor usage than HIV-1. Taken
together, these observations suggest that in vitro usage of the
CXCR-4 coreceptor and broadening of the coreceptor usage
by HIV-2 do not result in enhanced in vivo pathogenicity.
To further address this issue we studied the in vivo
pathogenic potential of HIV-2 isolates and biological clones in
a chimeric human-to-mouse model for in vivo HIV infection
[the xeno-GvHD (graft-versus-host disease) mouse model]
(Huppes et al., 1992, 1993 ; Schutten et al., 1996). In this model
high numbers of human PBMC are grafted into the peritoneal
cavity of immune-deficient mice. In these mice an acute graft-
versus-host reaction develops within 7 to 14 days. The human
lymphocyte population that repopulates the mouse tissues is
characterized by high CD4}CD8 ratios (Schutten et al., 1996).
Depletion of human CD4+ T cells from the graft results in a
complete abrogation of the acute xeno-GvHD reaction.
Depletion of antigen-presenting cells (APC; macrophages)
from the human graft results in lower CD4}CD8 ratios and a
concomitant delay in appearance of the xeno-GvHD symptoms
(Huppes et al., 1993). We therefore set out to study in this
model the direct (killing of infected CD4+ T cells) and indirect
(inhibition}modulation of antigen presentation) pathogenic
effect of different HIV-2 strains and isolates on the de-
velopment of acute xeno-GvHD symptoms, CD4}CD8 ratio
and the ability of the graft to repopulate mouse tissues.
Methods
+ Virus strains and xeno-GvHD mice. Xeno-GvHD mice were
prepared as described previously (Huppes et al., 1992, 1993 ; Schutten et
al., 1996). Briefly, 3–4-week-old XID mice (CBA}HNOlaHsd, Harlan
Netherlands) were given total body irradiation (9 Gy) with syngeneic
bone marrow support (5‹10& cells per mouse, intraveneously). Sub-
sequently, Ficoll-gradient-isolated human PBMC from HIV-seronegative
individuals (blood type A, Rhesus›) were given at 2‹10( per gram
mouse body weight intraperitoneally (i.p.). These xeno-GvHD mice were
challenged i.p. with HIV-2 within 1 h of being grafted with human
PBMC. Animals grafted with human PBMC from one and the same HIV-
seronegative blood donor were equally distributed over groups of five
mice receiving different HIV-2 strains. The primary HIV-2 strains used in
this study had been isolated in mitogen-stimulated PBMC only and the
in vitro characteristics have been described previously (van der Ende et al.,
1996 ; Guillon et al., 1998). Relevant virus characteristics are given in
Table 1. The doses of challenge virus were equilibrated on the basis of
c.p.m. measured in an RT assay (van Baalen et al., 1998) and equalled
approximately 30 mouse infectious doses 50% per mouse.
+ Parameters of acute xeno-GvHD reaction and HIV-2 in-
fection. Directly after the onset of acute xeno-GvHD symptoms (furry
coat, breathing problems and wasting), mice were sacrificed and
lymphocytes were isolated from the peritoneal cavity. Human-to-mouse
chimerism was confirmed and the CD4}CD8 ratio of the human graft was
calculated, using FACScan analysis with human CD3 and CD8 conjugates
(Becton Dickinson) according to the manufacturer’s instructions. The viral
loads of the lymphocytes isolated from the peritoneal cavities were
determined in an infectious centre assay (ICT) (Schutten et al., 1996).
Briefly, human lymphocytes isolated from the peritoneal cavity were
counted and titrated in duplicate from 2‹10& to 2 cells per well onward
using fivefold dilution steps in 96-well (round bottomed) plates. PBMC,
pre-stimulated with mitogen for 3 days, were added as feeder cells
(5‹10% per well). The cells were cultured for 7 days in RPMI 1640
(BioWhittaker) supplemented with 10% foetal calf serum (BioWhittaker),
penicillin (100 U}ml), streptomycin (10 lg}ml) and 50 IU recombinant
human IL-2}ml (Eurocetus), after which virus was detected by RT assay.
The minimal number of cells isolated from the peritoneal cavity required
for detection of virus was taken as a measure of the cell-associated viral
load.
+ HIV-2 in situ hybridization and immunohistochemistry.
Xeno-GvHD mouse tissues, including spleen, lung, bowel, heart, liver and
bone, were prepared from groups of mice which had been grafted with
PBMC isolated from the same individual. Tissues from two mice infected
with the same HIV-2 isolate}strain were analysed pairwise. Tissues were
fixed overnight with 4% formalin and subsequently embedded in paraffin.
For routine immunohistochemistry, dewaxed 5 lm paraffin sections were
heat-denatured with 0–01 M buffered sodium citrate (Norton et al., 1994).
The sections were incubated with CD45 (LCA) (Dakopatts) according to
the manufacturer’s instructions (Tenner-Racz et al., 1998). Binding of
antibodies was visualized by the alkaline phosphatase anti-alkaline
phosphatase technique using New Fuchsin as red chromogen. We have
previously shown that this conjugate does not stain mouse cells (Schutten
et al., 1996). After immunostaining the sections were either counter-
stained with haematoxylin and mounted, or dehydrated and subjected to
HIV RNA in situ hybridization. $&S-labelled, single-stranded, anti-sense
HIV-2 RNA probes (Lofstrand Laboratories), which contained 1–4–2–7 kb
fragments, collectively representing approximately 90% of the HIV-2
genome, were used as described previously (Embretson et al., 1993 ; Fox
et al., 1991). Briefly, paraffin sections were either treated with Proteinase
K (0–01 mg}ml) for 8 min at room temperature or heat denatured. The
sections were incubated with prehybridization mixture (50% formamide,
0–5 M NaCl, 10 mM Tris–HCl, pH 7–4, 1 mM EDTA, 0–02% Ficoll–
polyvinylpyrrolidone–BSA and 7 mg of tRNA}ml) for 2 h at 37 °C and
then covered with hybridization mixture (prehybridization mixture›
10% dextran sulfate and 2‹10’ d.p.m. of probe}ml) overnight at 45 °C.
The sections were washed, RNase treated (Boehringer Mannheim) for
40 min at 37 °C and further developed, counter-stained with haemalaun
and mounted as previously described. As a negative control, sections
were hybridized with a radiolabelled sense probe. The sections were
examined with a microscope equipped with epiluminescent illumination
(Axiophot ; Carl Zeiss). Cells were considered positive for viral gene
expression if the number of grains overlying a cell was more than six
times the background.
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Table 1. Characteristics of the HIV-2 strains
HIV-2
strain
Replication
rate*
Biological
phenotype
Coreceptor
usage Macrophage-tropism
RH2-1 42 Early NSI R5 ›
RH2-2 ! 7 Late SI R1,R3,R5,X4 fi
RH2-6 ! 7 Late SI X4 ›
PH2-1 E6 14 Intermediate NSI R1,R3,R5,X4 ›
PH2-1 D5 14 Intermediate SI R5 ›
* First day of a positive signal in p24 antigen ELISA after start of virus isolation (van der Ende et al., 1996).
 Biological phenotype according to van der Ende et al. (1996).
 Coreceptor usage according to Guillon et al. (1998) and Berger et al. (1998).
Results
Acute xeno-GvHD symptoms and CD4/CD8 ratio
Grafting human PBMC from HIV-seronegative individuals
at 2‹10( per gram mouse body-weight i.p. has been shown to
induce an acute xeno-GvHD reaction within 14 days in
approximately 100% of the animals (Huppes et al., 1992 ;
Schutten et al., 1996) (Table 2). In general, the development of
acute xeno-GvHD symptoms is fast and little variation is
observed between animals grafted with PBMC from donors
with the same ABO}Rhesus factor. The acute xeno-GvHD
symptoms observed in the HIV-2-infected xeno-GvHD mice
were in general less severe than in the control mice (Table 2).
No significant differences in absolute numbers of human
lymphocytes isolated from the peritoneal cavity (data not
Table 2. Acute xeno-GvHD symptoms in HIV-2-infected mice
Lung Spleen
HIV-2
strain
Xeno-
GvHD* ICT
CD4/CD8
ratio
CD45+
cells
HIV-2-infected
cellss
CD45+
cells
HIV-2-infected
cellss
– ›› – 4–9 ››› fi na –
RH2-1 › 1–6‹10# 0–8–1–2 ›› ››› ››› ›››
RH2-2 › 4‹10# 0–6–1–1 ›› › ››› ››
RH2-6 fi 3‹10# 0–3–0–5 fi fi fi fi
PH2-1 E6 › 2‹10$ 0–7–1–2 ›› ››› ››› ›››
PH2-1 D5 › 1–6‹10# 0–6–0–8 fi fi › ›
* Severity of the xeno-GvHD symptoms : ››, severe ; ›, minor ; fi, no symptoms observed within the
observation period (11 days).
 Number of infectious centres per 4‹10& cells isolated from the peritoneal cavity.
 Range of the CD4}CD8 ratio within each group of mice.
 Numbers of CD45+ cells in the organ : ›››, very high ; ››, high ; ›, low; fi, occasional positive
cell ; na, not applicable due to xeno-GvHD induced necrosis of the organ.
s Numbers of HIV-2-RNA-positive cells : ›››, very high ; ››, high ; ›, low; fi, occasional positive
cell.
shown) or in the number of infected centres in the ICT (Table
2) were observed between the different groups of HIV-2-
infected mice. Quite unexpectedly, no significant differences in
symptoms or CD4}CD8 ratio were observed between xeno-
GvHD mice infected with the early HIV-2 RH2-1 (R5) isolate
or late isolate HIV-2 RH2-2 (R1,R3,R5,X4). Acute xeno-GvHD
symptoms were not observed in the mice infected with the late
HIV-2 subtype B isolate RH2-6 (X4) and CD4}CD8 ratios
from these mice were lower compared to those in mice in the
other groups (Table 2). Although the differences between mice
infected with the SI and NSI biological clone from PH2-1 were
minor, the xeno-GvHD mice infected with the SI biological
clone PH2-1 D5 (R5) did show less severe xeno-GvHD
symptoms as compared to the mice infected with the NSI
biological clone PH2-1 E6 (R1,R3,R5,X4) (Table 2).
FAJ
M. E. van der Ende and others
Fig. 1. Comparison of the numbers of human lymphoid cells and productively HIV-2-infected cells in xeno-GvHD mice as
determined by CD45 staining (red alkaline phosphatase staining) and HIV-2 RNA in situ hybridization (black grains). (A)
Uninfected control ; (B) HIV-2 RH2-1 (R5) ; (C) HIV-2 RH2-2 (R1,R3,R5,X4) ; (D) HIV-2 RH2-6 (X4) ; (E) HIV-2 PH2-1 E6
(R1,R3,R5,X4) ; (F) HIV-2 PH2-1 D5 (R5).
Immunohistochemistry of tissues from xeno-GvHD
mice
In order to study the ability of the human PBMC graft to
repopulate the mouse tissues after infection with HIV-2, tissues
from the xeno-GvHD mice (spleen, lung, heart, bone, bowel)
were prepared and examined to determine the numbers human
cells present as indicated by immunohistochemical staining for
human CD45. Variation in the distribution of the human
lymphocytes was low between mice grafted with the same
donor PBMC (data not shown). High numbers of human cells,
especially in highly vascularized tissues like the lung, were
observed in xeno-GvHD mice which were uninfected (Table
2). Only small remnants of necrotized spleen could be obtained
from these mice, in which the mouse tissue was almost
completely replaced by human cells (Fig. 1A). Within these
tissues only CD45+CD68− cells (T cells) were found and
CD45+CD68+ cells (macrophages) were exclusively found
adhered to and migrating into tissues isolated from the
peritoneal cavity (Schutten et al., 1996). In all HIV-2-infected
xeno-GvHD mice, relatively high numbers of human T cells
and macrophages could be observed in the tissues isolated
from the peritoneal cavity. Similar to what was found for
uninfected mice, macrophages were exclusively found mi-
grating into and adhered to the tissues isolated from the
peritoneal cavity (data not shown). The numbers of human
FBA
HIV-2 coreceptor usage and pathogenicity
cells in the lungs of the xeno-GvHD mice infected with HIV-
2 RH2-1 (R5), RH2-2 (R1,R3,R5,X4) and PH2-1 E6 (R1,R3,
R5,X4) was significantly lower than the number of human cells
in the lungs of the control mice (Table 2). The structure of the
spleen obtained from these mice was relatively intact and
contained many CD45+ cells, mainly within the periarteriolar
lymphocyte sheets (Fig. 1B, C, E ; Table 2). Hardly any CD45+
cells were found in the lung and spleen of mice infected with
HIV-2 RH2-6 (X4) (Fig. 1D; Table 2). Similarly, the lungs of
HIV-2 PH2-1 D5 (R5)-infected mice was almost completely
devoid of human cells and low numbers of human cells were
observed in the spleen (Fig. 1F, Table 2).
HIV-2 infection of xeno-GvHD mice
The ability of the HIV-2 isolates and biological clones to
productively infect cells expressing the macrophage marker
CD68 was determined by double labelling (HIV-2 RNA in situ
hybridization with CD68 immunohistochemistry) (Table 1).
Productively infected macrophages were observed in all HIV-
2-infected xeno-GvHD mice except for those infected with the
late isolate RH2-2 (R1,R3,R5,X4) (Table 1). Also, the relative
number of productively infected cells was determined in the
tissues with high numbers of human lymphocytes (spleen and
lung) (Table 2). HIV-2 RNA in situ hybridization signal above
background was absent in the negative control mice. High
numbers of HIV-2 RNA+ cells were observed in the peritoneal
cavity of all mice infected with the different HIV-2 isolates and
biological clones (data not shown). High numbers of produc-
tively infected cells could be observed in the lungs and spleens
of xeno-GvHD mice infected with HIV-2 RH2-1 (R5) (Fig. 1C).
Despite the fact that no significant differences in the numbers
of CD45+ cells were observed between xeno-GvHD mice
infected with HIV-2 RH2-1 (R5) (Fig. 1C) or HIV-2 RH2-2
(R1,R3,R5,X4) (Fig. 1D), a significantly lower number of
productively infected cells was found in the tissues of xeno-
GvHD mice infected with HIV-2 RH2-2 (R1,R3,R5,X4) (Table
2). Similar to HIV-2 RH2-1 (R5)-infected xeno-GvHD mice,
many productively infected cells were found in the tissues of
xeno-GvHD mice infected with HIV-2 PH2-1 E6 (R1,R3,
R5,X4) (Fig. 1E, Table 2). Although the numbers of cells and
therefore also the numbers of productively infected cells in the
peripheral tissues of xeno-GvHD mice infected with HIV-2
PH2-1 D5 (R5) (Fig. 1F) were significantly lower as compared
to HIV-2 RH2-1 (R5), RH2-2 (R1,R3,R5,X4) and PH2-1 E6
(R1,R3,R5,X4), a relatively high percentage of the cells
observed in the peripheral tissues of these mice were still
productively infected (Table 2).
Discussion
In the present paper we have shown that the SI capacity,
replication rate and ability to infect macrophages influenced
the pathogenic properties of HIV-2 strains in the xeno-GvHD
mouse model for HIV infection. Moreover, an SI macrophage-
tropic HIV-2 biological clone that only uses CCR-5 as
coreceptor proved to be more pathogenic than a highly
homologous NSI macrophage-tropic biological clone with a
potentially broader coreceptor usage (CCR-1, CCR-3, CCR-5
and CXCR-4). These data suggest that broadening of the
potential cellular host-range does not necessarily increase the
pathogenic potential of HIV-2 and probably HIV-1.
Both direct and indirect mechanisms have been suggested
to contribute to the pronounced CD4+ T cell depletion
observed in HIV-infected individuals (for review see Zinker-
nagel et al., 1994). The direct mechanisms include acute single
cell lysis of infected cells (Samson et al., 1996) and depletion of
uninfected CD4+ cells by fusion with infected cells (syncytium
formation) (Tersmette et al., 1993). It has also been shown that
cells of the monocyte}macrophage lineage do not function
properly, which may result in dysregulation of activation
and}or maturation of CD4+ T cells due to functionally
disturbed antigen presentation (Meyaard et al., 1993). This
may also indirectly contribute to the decline of CD4+ T cells.
Two observations suggest that this last phenomenon con-
tributed to the HIV-2-induced CD4+ T cell depletion in our
xeno-GvHD mouse model. First, no significant differences
were observed in the CD4}CD8 ratio and the number of
CD45+ cells in spleens and lungs of mice infected with the
early, macrophage-tropic NSI isolate RH2-1 (R5) and the late
non-macrophage-tropic SI isolate RH2-2 (R1,R3,R5,X4). This is
despite the fact that the late SI isolate is highly cytopathic for
CD4+ T cells in vitro and the early NSI isolate does not induce
single cell lysis to a significant extent (unpublished obser-
vations). The fact that the percentage of infected cells was high
in the RH2-1 (R5)-infected mice and low in the RH2-2
(R1,R3,R5,X4)-infected mice also suggests that these virus
strains cause CD4+ T cell depletion by two different
mechanisms. It seems appropriate to assume that HIV-2 RH2-
2 (R1,R3,R5,X4)-infected cells are directly killed and therefore
do not reach the peripheral tissues studied, whereas RH2-1
(R5)-infected cells are not killed directly, but seem rather to be
functionally affected. Second, RH2-2 (R1,R3,R5,X4) and RH2-
6 (X4) are both highly cytopathic for CD4+ T cells in vitro. The
macrophage-tropic isolate RH2-6 (X4) proved to be far more
pathogenic in vivowith respect to abrogatingGvHDsymptoms
and inhibiting migration of T cells to peripheral tissues than the
non-macrophage-tropic isolate RH2-2 (R1,R3,R5,X4).
SI capacity, replication rate and coreceptor requirements
have all been shown to positively correlate with rapid disease
progression in HIV-1-infected individuals. Because, for HIV-1,
these factors are generally linked, it has not been possible to
distinguish which factors have a causal relation with disease
progression. Since SI capacity and coreceptor usage are not
linked for HIV-2, we could study these factors independently.
The observation that in vitro coreceptor usage of HIV-2 strains
is broader than that of HIV-1 has already suggested that
broadening of coreceptor usage does not necessarily lead to
increased in vivo pathogenicity. Indeed, in the xeno-GvHD
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model, RH2-6 (X4) proved to be far more pathogenic with
regard to all aspects studied than RH2-2 (R1,R3,R5,X4),
suggesting that broadening of coreceptor usage does not
significantly add to the in vivo pathogenicity. This is further
supported by the observation that the NSI biological clone
PH2-1 E6 (R1,R3,R5,X4) was less well able to inhibit migration
of T cells and may therefore be regarded more pathogenic than
its SI counterpart PH2-1 D5 (R5).
We have recently shown that the number of productively
infected cells in lymphoid tissue from HIV-2-infected indi-
viduals is significantly lower than in HIV-1-infected indi-
viduals. Furthermore, it has been shown that the number of
productively infected cells is positively correlated with the
plasma viral load, which is in turn correlated with disease
progression. Interestingly, we did not observe major dif-
ferences in cell-associated viral loads or in pathogenicity of the
HIV-2 strains tested when compared with previously studied
HIV-1 strains (Schutten et al., 1996). It therefore seems that in
the absence of a substantial humoral and cellular antiviral
immune response both in vitro and in our human-to-mouse
chimeric model, HIV-1 and HIV-2 may have comparable
replicative and pathogenic potential. We therefore hypothesize
that the lower viral load and pathogenicity observed in HIV-
2-infected individuals as compared to HIV-1-infected indi-
viduals is primarily related to a difference in interaction of the
virus with the specific immune response.
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